Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

NCT07194044 is registered in ClinicalTrials.gov with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor.

NCT NCT07194044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07194044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Phase
Phase 1
Overall status
Recruiting
Start date
February 5, 2026
Completion date
October 31, 2030
Enrollment
15 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic ewing sarcoma